Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes

Bibliographic Details
Main Authors: Yun-Mi Jang, Dong-Lim Kim
Format: Article
Language:English
Published: Korean Diabetes Association 2011-04-01
Series:Diabetes & Metabolism Journal
Online Access:http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-35-117.pdf
_version_ 1818465899881955328
author Yun-Mi Jang
Dong-Lim Kim
author_facet Yun-Mi Jang
Dong-Lim Kim
author_sort Yun-Mi Jang
collection DOAJ
first_indexed 2024-04-13T20:51:59Z
format Article
id doaj.art-93ef118b29ac48ceae60d7da151be07a
institution Directory Open Access Journal
issn 2233-6079
2233-6087
language English
last_indexed 2024-04-13T20:51:59Z
publishDate 2011-04-01
publisher Korean Diabetes Association
record_format Article
series Diabetes & Metabolism Journal
spelling doaj.art-93ef118b29ac48ceae60d7da151be07a2022-12-22T02:30:29ZengKorean Diabetes AssociationDiabetes & Metabolism Journal2233-60792233-60872011-04-0135211711810.4093/dmj.2011.35.2.1172737Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 DiabetesYun-Mi JangDong-Lim Kimhttp://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-35-117.pdf
spellingShingle Yun-Mi Jang
Dong-Lim Kim
Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
Diabetes & Metabolism Journal
title Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
title_full Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
title_fullStr Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
title_full_unstemmed Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
title_short Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
title_sort candidate dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes
url http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-35-117.pdf
work_keys_str_mv AT yunmijang candidatedipeptidylpeptidase4inhibitorsforthetreatmentoftype2diabetes
AT donglimkim candidatedipeptidylpeptidase4inhibitorsforthetreatmentoftype2diabetes